Abstract
Stroke is still a major cause of morbidity and mortality throughout the world, although better stratification and treatment modalities are being developed. As compared to ischemic stroke, intracerebral hemorrhage (ICH) possesses many unknown data and lacks guidelines for better prophylaxis. In this study, we aimed to investigate patients with ICH hospitalized in our neurology department within 5 years in terms of risk stratification. A total of 4,449 patients were hospitalized; 1,378 of patients (31 %) were diagnosed as having cerebrovascular disease and of these 165 patients (3.7 %) had ICH. The risk factors of patients with ICH were investigated and compared with age- and gender matched 75 healthy subjects. We observed that hypercholesterolemia (p = 0.002) was one of the most common risk factors in patients with ICH as compared to controls, together with hypertension (p = 0.010). On the other hand, hypolipidemia (LDL-cholesterol level < 50 mg/dl) was not present in any of the patients. As our purpose as neurologists is to reduce the occurrence and fatal outcome of cerebrovascular events, we aimed to emphasize the importance of risk factors to be well defined, for which every effort should be exhibited for both primary and secondary prevention.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carhuopama JR, Mayer SA, Hanley DF (2010) Intracerebral Hemorrhage. The epidemiology of intracerebral hemorrhage. Cambridge University Press, Cambridge, pp 1–15
Kase CS, Mohr JP, Caplan LR (2004) Stroke: pathophysiology, diagnosis, and management risk. Intracerebral Hemorrhage 13:327–376
Bejot Y, Osseby GV, Gremeaux V, Durier J, Rouaud O, Moreau T, Giroud M (2009) Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study. J Neurol Sci 287:84–88
Siracuse JJ, Robich MP, Gautam S, Kasper EM, Moorman DW, Hauser CJ (2010) Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage. Surgery 148:724–730
Nago N, Ishikawa S, Goto T, Kayaba K (2011) Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School cohort study. J Epidemiol 21:67–74
Suzuki K, Izumi M, Sakamato T, Hayashi M (2011) Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis 31:100–106
Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63:1868–1875
Tveiten A, Ljostad U, Mygland A, Thomassen L, Pripp AH, Naes H (2012) Intracerebral hemorrhage in Southern Norway—a hospital-based incidence study. Eur Neurol 67:240–245
Kim YZ, Park YH, Song YG, Kim KH (2012) Clinical analysis of factors predisposing the recurrence of primary intracerebral hemorrhage in patients taking anti-hypertensive drugs: a prospective cohort study. Clin Neurol Neurosurg 3033:1–9
Soo YOY, Siu DYW, Abrigo J, Yu S, Ng N, Ahuja AT, Wong LKS, Leung TW (2012) Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke 43:1532–1536
Hankey GJ, Wong KSL, Chankrachang S, Chen C, Crimmins D, Frayne J, Kim JS, Li Y, Liou CW, Merican JS, Misbach J, Navarro J, Shinohara Y, Wang Y, Yoon BW (2010) Management of cholesterol to reduce the burden of stroke in Asia: consensus statement. Int J Stroke 5:209–216
Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G (2012) Total and high-density lipoprotein cholesterol and stroke risk. Stroke 43:1768–1774
Ikram MA, Wieberdink RG, Koudstaal PJ (2012) International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 14:300–306
Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, Mac Leod MJ, Sillesen H, Zweifler R, Michael K, Welch A, Behalf of SPARCL Investigators (2009) Statin treatment and stroke outcome in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke 40:3526–3531
LaRosa JC, Pedersen TR, Somaratne R, Wasserman SM (2013) Safety and effect of very low levels of low density lipoprotein cholesterol on cardiovascular events. Am J Cardiol 111:1221–1229
Collins R, Armitage J, Parish S, Sleight P, Peto R (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363:757–767
Ramjee V, Jacobson TA (2011) Intensifying statin therapy to maximize cardiovascular risk reduction: is 50 the new 70? goals are getting old. Clin Lipidol 6:131–136
Oguz A, Temizhan A, Gulec S, Altuntas Y, Karsıdag K, Akalın AAK, Calık BT, Imeryuz N (2011) Dyslipidemia rates in age group 35–70 in Turkey. Obes Rev 7:581–582
Abacı (2011) The current status of cardiovascular risk factors in Turkey. Arch Turk Soc Cardiol 39 (Suppl 4):1–5
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bozluolcay, M., Nalbantoglu, M., Gozubatik-Celik, R.G. et al. Hypercholesterolemia as one of the risk factors of intracerebral hemorrhage. Acta Neurol Belg 113, 459–462 (2013). https://doi.org/10.1007/s13760-013-0222-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-013-0222-6